Literature DB >> 34669180

Corticothalamic Connectivity in Aneurysmal Subarachnoid Hemorrhage: Relationship with Disordered Consciousness and Clinical Outcomes.

Peter B Forgacs1, Baxter B Allen1, Xian Wu2, Linda M Gerber2, Srikanth Boddu3, Malik Fakhar1,4, Philip E Stieg3, Nicholas D Schiff1, Halinder S Mangat5,6.   

Abstract

BACKGROUND: We present an exploratory analysis of the occurrence of early corticothalamic connectivity disruption after aneurysmal subarachnoid hemorrhage (SAH) and its correlation with clinical outcomes.
METHODS: We conducted a retrospective study of patients with acute SAH who underwent continuous electroencephalography (EEG) for impairment of consciousness. Only patients undergoing endovascular aneurysm treatment were included. Continuous EEG tracings were reviewed to obtain artifact-free segments. Power spectral analyses were performed, and segments were classified as A (only delta power), B (predominant delta and theta), C (predominant theta and beta), or D (predominant alpha and beta). Each incremental category from A to D implies greater preservation of corticothalamic connectivity. We dichotomized categories as AB for poor connectivity and CD for good connectivity. The modified Rankin Scale score at follow-up and in-hospital mortality were used as outcome measures.
RESULTS: Sixty-nine patients were included, of whom 58 had good quality EEG segments for classification: 28 were AB and 30 were CD. Hunt and Hess and World Federation of Neurological Surgeons grades were higher and the initial Glasgow Coma Scale score was lower in the AB group compared with the CD group. AB classification was associated with an adjusted odds ratio of 5.71 (95% confidence interval 1.61-20.30; p < 0.01) for poor outcome (modified Rankin Scale score 4-6) at a median follow-up of 4 months (interquartile range 2-6) and an odds ratio of 5.6 (95% confidence interval 0.98-31.95; p = 0.03) for in-hospital mortality, compared with CD.
CONCLUSIONS: EEG spectral-power-based classification demonstrates early corticothalamic connectivity disruption following aneurysmal SAH and may be a mechanism involved in early brain injury. Furthermore, the extent of this disruption appears to be associated with functional outcome and in-hospital mortality in patients with aneurysmal SAH and appears to be a potentially useful predictive tool that must be validated prospectively.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.

Entities:  

Keywords:  Corticothalamic connectivity; Functional outcome; Mesocircuit; Mortality; Subarachnoid hemorrhage

Mesh:

Year:  2021        PMID: 34669180     DOI: 10.1007/s12028-021-01354-6

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  37 in total

1.  Incidence and outcome of subarachnoid haemorrhage: a retrospective population based study.

Authors:  L H Pobereskin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

2.  Has Outcome of Subarachnoid Hemorrhage Changed With Improvements in Neurosurgical Services?

Authors:  Sivashanmugam Dhandapani; Apinderpreet Singh; Navneet Singla; Kokkula Praneeth; Ashish Aggarwal; Harsimrat B Sodhi; Sudhir S Pal; Sachin Goudihalli; Pravin Salunke; Sandeep Mohindra; Ajay Kumar; Vivek Gupta; Rajesh Chhabra; Kanchan K Mukherjee; Manoj K Tewari; Niranjan Khandelwal; Suresh N Mathuriya; Virender K Khosla; Sunil K Gupta
Journal:  Stroke       Date:  2018-12       Impact factor: 7.914

3.  Continuous electroencephalography predicts delayed cerebral ischemia after subarachnoid hemorrhage: A prospective study of diagnostic accuracy.

Authors:  Eric S Rosenthal; Siddharth Biswal; Sahar F Zafar; Kathryn L O'Connor; Sophia Bechek; Apeksha V Shenoy; Emily J Boyle; Mouhsin M Shafi; Emily J Gilmore; Brandon P Foreman; Nicolas Gaspard; Thabele M Leslie-Mazwi; Jonathan Rosand; Daniel B Hoch; Cenk Ayata; Sydney S Cash; Andrew J Cole; Aman B Patel; M Brandon Westover
Journal:  Ann Neurol       Date:  2018-05-16       Impact factor: 10.422

4.  Improved aneurysmal subarachnoid hemorrhage outcomes: a comparison of 2 decades at an academic center.

Authors:  Neeraj Sunderrajan Naval; Tiffany Chang; Filissa Caserta; Robert G Kowalski; Juan Ricardo Carhuapoma; Rafael J Tamargo
Journal:  J Crit Care       Date:  2012-07-24       Impact factor: 3.425

5.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

6.  Improved survival after aneurysmal subarachnoid hemorrhage: review of case management during a 12-year period.

Authors:  K G Cesarini; H G Hårdemark; L Persson
Journal:  J Neurosurg       Date:  1999-04       Impact factor: 5.115

7.  Time Trends in Outcomes After Aneurysmal Subarachnoid Hemorrhage Over the Past 30 Years.

Authors:  Biagia La Pira; Tarun D Singh; Alejandro A Rabinstein; Giuseppe Lanzino
Journal:  Mayo Clin Proc       Date:  2018-12       Impact factor: 7.616

8.  The Barrow Neurological Institute Scale Revisited: Predictive Capabilities for Cerebral Infarction and Clinical Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage.

Authors:  Nora F Dengler; Dominik Diesing; Asita Sarrafzadeh; Stefan Wolf; Peter Vajkoczy
Journal:  Neurosurgery       Date:  2017-08-01       Impact factor: 4.654

9.  Ultra-early versus delayed coil treatment for ruptured poor-grade aneurysm.

Authors:  Yong-Chun Luo; Chun-Sen Shen; Jin-Long Mao; Chun-Yang Liang; Qiang Zhang; Zi-Jun He
Journal:  Neuroradiology       Date:  2014-10-17       Impact factor: 2.804

Review 10.  Seizures and Epileptiform Patterns in SAH and Their Relation to Outcomes.

Authors:  Carolina B Maciel; Emily J Gilmore
Journal:  J Clin Neurophysiol       Date:  2016-06       Impact factor: 2.177

View more
  1 in total

Review 1.  Electroencephalogram in the intensive care unit: a focused look at acute brain injury.

Authors:  Ayham Alkhachroum; Brian Appavu; Benjamin Rohaut; Jan Claassen; Satoshi Egawa; Brandon Foreman; Nicolas Gaspard; Emily J Gilmore; Lawrence J Hirsch; Pedro Kurtz; Virginie Lambrecq; Julie Kromm; Paul Vespa; Sahar F Zafar
Journal:  Intensive Care Med       Date:  2022-08-23       Impact factor: 41.787

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.